美迪斯沃（北京）医药科技有限公司

公司简介

美迪斯沃（北京）医药科技有限公司，由业内专业人士组建，秉承“以真诚与科技为客户创造价值”的服务理念；帮助合作伙伴预测并有效降低新产品投资风险与市场推广风险，为中国优秀医药企业研发提供全方位解决方案。    领导人为协和医学院流行病与卫生统计博士背景，17年GCP临床经验，曾就职于凯维斯、PPD跨国CRO企业。服务项目：1. 申报资料撰写、医学设计、医学翻译2. 临床试验：I-IV期药物临床试验、器械临床试验公司优势：1.整体解决优势： 提供临床研究整体解决方案2.核心团队优势： 平均10年以上GCP临床研究经验3.质量保障优势： 完整的质量保障体系4.专家资源优势： 千名合作专家资源5.信息资源优势： 研发、生产、临床全方位信息6.服务网络优势： 覆盖全国主要区域Med-S (Beijing) Medical Technology Company is a contract research organization (CRO) . Med-S works with the commitment to consistent quality and execution, exceptional customer-aligned service and constant innovation to speed the overall execution of clinical trials. Med-S’ strategy is to bend the time and cost curve of drug development and optimize value for our customers.The funder of Med-S has a MD degree of Epidemiology and Biostatistics of the Peking Union Medical College who has 17 years experience of clinical research and funded Med-S following more than 10 years with KendleWits and PPD.Med-S focus on/in:1.    Providing contract personnel for clinical development relative position;2.    Medical writing and translation;3.    Providing medical report for on-sale drugs using hospital HIS data;4.    SMO;5.    Services on Phase I-IV clinical trials;6.    Services on clinical trials for medical device, diagnostic reagent products;7.    Patient enrolment.Our superiority:1.    One-stop solution: we provide customer special one-stop solutions for clinical trial.2.    Core service team: member of the core service team has an average of 10 years experience in GCP clinical trials.3.    Quality assurance system: has comprehensive QA system.4.    Expert resource: well cooperated with near 1000 clinical experts and keep cooperation.5.    News resource: news related to development, production, and clinical trials.6.    Site network: have sites in main cities in China.